Comparison of inductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry with quantitative neutron capture radiography for the determination of boron in biological samples from cancer therapy

被引:48
作者
Probst, TU
Berryman, NG
Lemmen, P
Weissfloch, L
Auberger, T
Gabel, D
Carlsson, J
Larsson, B
机构
[1] TECH UNIV MUNICH, INST ORGAN CHEM & BIOCHEM, D-85747 GARCHING, GERMANY
[2] TECH UNIV MUNICH, KLINIKUM RECHTS ISAR, CLIN & POLYCLIN RADIOTHERAPY & RADIOL ONCOL, D-81675 MUNICH, GERMANY
[3] UNIV INNSBRUCK, CLIN RADIOTHERAPY, A-6020 INNSBRUCK, AUSTRIA
[4] UNIV BREMEN, DEPT CHEM, D-28334 BREMEN, GERMANY
[5] UNIV UPPSALA, DEPT RADIAT SCI, DIV PHYS BIOL, S-75121 UPPSALA, SWEDEN
[6] PAUL SCHERRER INST, CH-5232 VILLIGEN, SWITZERLAND
关键词
inductively coupled plasma mass spectrometry; inductively coupled plasma atomic emission spectrometry; quantitative neutron capture radiography; boron neutron capture therapy; cancer therapy; microwave digestion rac-1-(9-o-carboranyl)nonyl-2-methylglycero-3-phosphocholine;
D O I
10.1039/a700445a
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A boron-containing compound was administered to tumor-bearing mice and the time-dependent concentration was determined by ICP-AES, ICP-MS and quantitative neutron capture radiography (QNCR). The atomic spectrometric procedures were optimized to minimize analyte losses during microwave digestion. Non-spectroscopic interferences were investigated in detail and appropriate internal standards were established for ICP-MS. The best detection limits achieved for boron were 30 ng ml(-1) by ICP-AES and 0.3 ng ml(-1) by ICP-MS. The respective determination limits in the digested and diluted tissue samples were 0.4 mu g ml(-1) and 3 ng ml(-1). The results of the spectrometric determinations were confirmed by QNCR of whole-body cryosections of six mice, A brief description of the metabolism of the boron compound is given.
引用
收藏
页码:1115 / 1122
页数:8
相关论文
共 70 条
[31]  
HONDA C, 1990, Journal of Dermatological Science, V1, P23, DOI 10.1016/0923-1811(90)90006-Y
[32]   A UNIQUE INVIVO ASSESSMENT OF 4-[B-10]BORONO-L-PHENYLALANINE IN TUMOR-TISSUES FOR BORON NEUTRON-CAPTURE THERAPY OF MALIGNANT MELANOMAS USING POSITRON EMISSION TOMOGRAPHY AND 4-BORONO-2-[F-18]FLUORO-L-PHENYLALANINE [J].
ISHIWATA, K ;
SHIONO, M ;
KUBOTA, K ;
YOSHINO, K ;
HATAZAWA, J ;
IDO, T ;
HONDA, C ;
ICHIHASHI, M ;
MISHIMA, Y .
MELANOMA RESEARCH, 1992, 2 (03) :171-179
[33]  
JOEL D, 1989, STRAHLENTHER ONKOL, V165, P167
[34]   DETERMINATION OF NANOGRAM LEVELS OF BORON IN MILLIGRAM-SIZED TISSUE SAMPLES BY INDUCTIVELY COUPLED PLASMA ATOMIC EMISSION-SPECTROSCOPY [J].
JOHNSON, DA ;
SIEMER, DD ;
BAUER, WF .
ANALYTICA CHIMICA ACTA, 1992, 270 (01) :223-230
[35]   VOLATILIZATION OF SOME ELEMENTS FROM A GRAPHITE ROD DIRECT SAMPLE INSERTION DEVICE INTO AN INDUCTIVELY COUPLED ARGON PLASMA FOR OPTICAL-EMISSION SPECTROMETRY [J].
KIRKBRIGHT, GF ;
ZHANG, LX .
ANALYST, 1982, 107 (1275) :617-622
[36]   IN-VIVO NMR OF DRUGS [J].
KOMOROSKI, RA .
ANALYTICAL CHEMISTRY, 1994, 66 (20) :A1024-A1033
[37]  
Krachler M, 1996, FRESEN J ANAL CHEM, V355, P120
[38]  
Kucharkoski R, 1996, FRESEN J ANAL CHEM, V355, P256
[39]  
LASTER BH, 1993, ADVANCES IN NEUTRON CAPTURE THERAPY, P535
[40]   The biological effects of Auger electrons compared to alpha-particles and Li ions [J].
Laster, BH ;
Shani, G ;
Kahl, SB ;
Warkentien, L .
ACTA ONCOLOGICA, 1996, 35 (07) :917-923